NCT04974125

Brief Summary

This is a phase III, monocenter and randomized study, which evaluates the effectiveness of peritoneal gas drainage on postoperative pain in laparoscopic or robotic laparoscopic gynaecological surgery. This study aim is to assess the efficacy of active gas extraction with a drain (arm A) in comparison to manual evacuation (arm B,) in terms of pain incidence reduction linked to laparoscopic or robotic laparoscopic surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
202

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 6, 2021

Completed
3 months until next milestone

First Posted

Study publicly available on registry

July 23, 2021

Completed
6 months until next milestone

Study Start

First participant enrolled

January 7, 2022

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 11, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 11, 2023

Completed
Last Updated

March 18, 2026

Status Verified

March 1, 2026

Enrollment Period

1.9 years

First QC Date

May 6, 2021

Last Update Submit

March 16, 2026

Conditions

Keywords

Postoperative painPeritoneal gas drainageLaparoscopic gynaecological surgeryRobotised laparoscopic gynaecological surgery

Outcome Measures

Primary Outcomes (1)

  • Specific pain (shoulders and/or subcostal areas) related to the laparoscopic surgery (Day 0), measured with a numerical pain assessment scale (score from 0 to 10)

    Comparison on portion of patients with significative early pain linked to the laparoscopic surgery, between the two groups (Chi-2 tests).

    During the 24 hours after surgery

Secondary Outcomes (7)

  • Maximal score pain, measured with a numerical pain assessment scale (score from 0 to 10)

    24 hours after surgery

  • Assess pain at trocar holes comparatively in the two groups

    24 hours after surgery

  • Laparoscopic surgery specific pains, measured with a numerical pain assessment scale (score from 0 to 10)

    7 days after surgery

  • Antalgics consumption

    24 hours and 7 days after surgery

  • Antalgics consumption

    24 hours and 7 days after surgery

  • +2 more secondary outcomes

Study Arms (2)

Arm A :Aspiration of peritoneal gas through a drain

EXPERIMENTAL

Patients in experimental arm will receive surgery (either laparoscopic or robotised laparoscopic surgery). The exsufflation will be carrying out by a drain. Then, patients will be followed-up during 7 days after surgery.

Procedure: Drain

Arm B : Manual evacuation of the peritoneal gas, via the trocar

ACTIVE COMPARATOR

Laparoscopic or robotised laparoscopic surgery + Trocar Patient in this experimental arm will receive surgery (either laparoscopic or robotised laparoscopic surgery). The exsufflation will be carrying out carried out manually using the trocar (standard of care).Then, patient will be followed-up during 7 days after surgery.

Procedure: Manual exsufflation

Interventions

DrainPROCEDURE

A 10 mm suction drain is placed through a trocar in the right hypochondrium (liver).

Arm A :Aspiration of peritoneal gas through a drain

Exsufflation through the trocar opening.

Arm B : Manual evacuation of the peritoneal gas, via the trocar

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsGynaecological cancer
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 ans ;
  • Woman who underwent laparoscopic or robotised laparoscopic surgery in peritoneal cavity (benign or malignant gynaecological affection) ;
  • Planned ambulatory surgery
  • Patient willing and able to be treated and followed according the protocol during the trial ;
  • Patient covered by the French "Social Security" regime ;
  • Effective contraception for reproductive age patients ;
  • Signed written informed consent before surgery
  • Per-operatory eligibility criterion :
  • No conversion from laparoscopic surgery to laparotomy surgery

You may not qualify if:

  • Extra-peritoneal surgery scheduled ( example : aortic dissection) ;
  • Upper-abdomen surgery (example : liver, gall bladder) ;
  • History of shoulders pains prior to surgery (the assessment must be carried out within a period of 30 days before the surgery) ;
  • Inability to comply with medical follow-up of the trial (geographical, social or psychic reasons)
  • Person under guardianship
  • Pregnant or breastfeeding woman
  • Non eligibility criterion known during the operation :
  • Conversion from laparoscopic surgery to laparotomy surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fabrice NARDUCCI

Lille, 59020, France

Location

MeSH Terms

Conditions

Pain, Postoperative

Interventions

Drainage

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

TherapeuticsSurgical Procedures, Operative

Study Officials

  • Fabrice NARDUCCI, PhD

    Centre Oscar Lambret

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Patient will be pre-selected before medical operation. During the surgery, if the surgeon performs only the laparoscopy, the patient will be randomized. Then, the allocated procedure (with or without drain) will be carried out.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 6, 2021

First Posted

July 23, 2021

Study Start

January 7, 2022

Primary Completion

December 11, 2023

Study Completion

December 11, 2023

Last Updated

March 18, 2026

Record last verified: 2026-03

Locations